உலர்ந்த கண் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலர்ந்த கண் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலர்ந்த கண் மையம் Today - Breaking & Trending Today

SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease


SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease
ProGIFT is a 3 arms, multicenter, randomized, double-masked clinical trial in Italy.
CATANIA, Italy, April 27, 2021 /PRNewswire/ SIFI announced today the enrollment of the first patients in the ProGIFT trial (NCT04645446), which aims at evaluating the safety and efficacy of Pro-ocular, a progesterone based topical gel in patients with Dry Eye Disease (DED). ProGIFT (NCT04645446) is a multicenter, randomized, double-masked, placebo-controlled Phase II clinical trial comparing different concentrations of Pro-ocular (1% and 0.5%)
versus placebo. The trial involves 4 leading ophthalmic centers in Italy specialized on disorders of the ocular surface and is expected to recruit 105 participants. ....

United States , Kostenloser Wertpapierhandel , Ospedalel Sacco , Stefano Barabino , Sebastiano Giuffrida , Head Of Clinical Development , World Health Organization , Eye Center , University Of Milan , Dry Eye Disease , Clinical Development , Ocular Surface , Dry Eye Center , Principal Investigator , ஒன்றுபட்டது மாநிலங்களில் , செபாஸ்டியானோ கீஉப்ப்ரிட , தலை ஆஃப் மருத்துவ வளர்ச்சி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , கண் மையம் , பல்கலைக்கழகம் ஆஃப் மிலன் , உலர்ந்த கண் நோய் , மருத்துவ வளர்ச்சி , கண் மேற்பரப்பு , உலர்ந்த கண் மையம் , ப்ரிந்ஸிபல் புலனாய்வாளர் ,

Regener Eyes: First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Art Epstein


(1)
PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes
®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board.
We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company s efforts, commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes
®. We are honored to add Dr. Epstein to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter and Dr. Ahmed Fahmy. ....

United States , Scott Schacter , Walt Whitley , Eric Donnenfeld , Ahmed Fahmy , Paul Karpecki , C Randall Harrell , Heidi Hart Pukas , Marguerite Mcdonald , Kostenloser Wertpapierhandel , Ocular Surface Disease Center , Eye Center , American Academy Of Optometry , Clinical Research , Practitioner Of The National Academies Practice , Bart Epstein , Clinical Advisory , Phoenix Eye Care , Dry Eye , Surface Disease Center , Dry Eye Center , Adjunct Associate Professor , Midwestern University Arizona College , American Academy , Distinguished Practitioner , National Academies ,